Literature DB >> 24610891

Hepatic ATGL mediates PPAR-α signaling and fatty acid channeling through an L-FABP independent mechanism.

Kuok Teong Ong1, Mara T Mashek, Nicholas O Davidson, Douglas G Mashek.   

Abstract

Adipose TG lipase (ATGL) catalyzes the rate-limiting step in TG hydrolysis in most tissues. We have shown that hepatic ATGL preferentially channels hydrolyzed FAs to β-oxidation and induces PPAR-α signaling. Previous studies have suggested that liver FA binding protein (L-FABP) transports FAs from lipid droplets to the nucleus for ligand delivery and to the mitochondria for β-oxidation. To determine if L-FABP is involved in ATGL-mediated FA channeling, we used adenovirus-mediated suppression or overexpression of hepatic ATGL in either WT or L-FABP KO mice. Hepatic ATGL knockdown increased liver weight and TG content of overnight fasted mice regardless of genotype. L-FABP deletion did not impair the effects of ATGL overexpression on the oxidation of hydrolyzed FAs in primary hepatocyte cultures or on serum β-hydroxybutyrate concentrations in vivo. Moreover, L-FABP deletion did not influence the effects of ATGL knockdown or overexpression on PPAR-α target gene expression. Taken together, we conclude that L-FABP is not required to channel ATGL-hydrolyzed FAs to mitochondria for β-oxidation or the nucleus for PPAR-α regulation.

Entities:  

Keywords:  adipose triglyceride lipase; liver fatty acid binding protein; peroxisome proliferator-activated receptor-α; β-oxidation

Mesh:

Substances:

Year:  2014        PMID: 24610891      PMCID: PMC3995459          DOI: 10.1194/jlr.M039867

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  44 in total

1.  Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation.

Authors:  Alex W Cohen; Babak Razani; William Schubert; Terence M Williams; Xiao Bo Wang; Puneeth Iyengar; Dawn L Brasaemle; Philipp E Scherer; Michael P Lisanti
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

2.  Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver.

Authors:  C Wolfrum; T Börchers; J C Sacchettini; F Spener
Journal:  Biochemistry       Date:  2000-02-15       Impact factor: 3.162

3.  Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene.

Authors:  Gregory G Martin; Heike Danneberg; Leena S Kumar; Barbara P Atshaves; Erdal Erol; Michael Bader; Friedhelm Schroeder; Bert Binas
Journal:  J Biol Chem       Date:  2003-04-01       Impact factor: 5.157

4.  Movement of lipolytic products to mitochondria in brown adipose tissue of young rats: an electron microscope study.

Authors:  E J Blanchette-Mackie; R O Scow
Journal:  J Lipid Res       Date:  1983-03       Impact factor: 5.922

5.  Substrate inhibition of carnitine palmitoyltransferase by palmitoyl-CoA and activation by phospholipids and proteins.

Authors:  G Woldegiorgis; J Bremer; E Shrago
Journal:  Biochim Biophys Acta       Date:  1985-11-14

6.  Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice.

Authors:  Erdal Erol; Leena S Kumar; Gary W Cline; Gerald I Shulman; Daniel P Kelly; Bert Binas
Journal:  FASEB J       Date:  2003-12-04       Impact factor: 5.191

7.  Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription.

Authors:  Nguan-Soon Tan; Natacha S Shaw; Nicolas Vinckenbosch; Peng Liu; Rubina Yasmin; Béatrice Desvergne; Walter Wahli; Noa Noy
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Diet-induced obesity and hepatic steatosis in L-Fabp / mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation.

Authors:  Elizabeth P Newberry; Susan M Kennedy; Yan Xie; Britni T Sternard; Jianyang Luo; Nicholas O Davidson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-11-21       Impact factor: 4.052

9.  Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene.

Authors:  Elizabeth P Newberry; Yan Xie; Susan Kennedy; Xianlin Han; Kimberly K Buhman; Jianyang Luo; Richard W Gross; Nicholas O Davidson
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

10.  Organelle relationships in cultured 3T3-L1 preadipocytes.

Authors:  A B Novikoff; P M Novikoff; O M Rosen; C S Rubin
Journal:  J Cell Biol       Date:  1980-10       Impact factor: 10.539

View more
  22 in total

1.  Liver Perilipin 5 Expression Worsens Hepatosteatosis But Not Insulin Resistance in High Fat-Fed Mice.

Authors:  Michelle B Trevino; David Mazur-Hart; Yui Machida; Timothy King; Joseph Nadler; Elena V Galkina; Arjun Poddar; Sucharita Dutta; Yumi Imai
Journal:  Mol Endocrinol       Date:  2015-08-21

2.  Serum FABP1 Levels Correlate Positively with Obesity in Chinese Patients After Laparoscopic Sleeve Gastrectomy: a 12-Month Follow-up Study.

Authors:  Hui You; Xin Wen; Cuiling Zhu; Ming Chen; Liting Dong; Yanli Zhu; Liu Yang; Le Bu; Manna Zhang; Donglei Zhou; Liesheng Lu; Lei Du; Ziwei Lin; Shen Qu
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

Review 3.  Physiological Consequences of Compartmentalized Acyl-CoA Metabolism.

Authors:  Daniel E Cooper; Pamela A Young; Eric L Klett; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2015-06-29       Impact factor: 5.157

Review 4.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

5.  Impact of SCP-2/SCP-x gene ablation and dietary cholesterol on hepatic lipid accumulation.

Authors:  Devon Klipsic; Danilo Landrock; Gregory G Martin; Avery L McIntosh; Kerstin K Landrock; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-25       Impact factor: 4.052

6.  ATGL Promotes Autophagy/Lipophagy via SIRT1 to Control Hepatic Lipid Droplet Catabolism.

Authors:  Aishwarya Sathyanarayan; Mara T Mashek; Douglas G Mashek
Journal:  Cell Rep       Date:  2017-04-04       Impact factor: 9.423

7.  Lipophagy-derived fatty acids undergo extracellular efflux via lysosomal exocytosis.

Authors:  Wenqi Cui; Aishwarya Sathyanarayan; Michael Lopresti; Mariam Aghajan; Chi Chen; Douglas G Mashek
Journal:  Autophagy       Date:  2020-02-19       Impact factor: 16.016

8.  Lipid Droplet-Derived Monounsaturated Fatty Acids Traffic via PLIN5 to Allosterically Activate SIRT1.

Authors:  Charles P Najt; Salmaan A Khan; Timothy D Heden; Bruce A Witthuhn; Minervo Perez; Jason L Heier; Linnea E Mead; Mallory P Franklin; Kenneth K Karanja; Mark J Graham; Mara T Mashek; David A Bernlohr; Laurie Parker; Lisa S Chow; Douglas G Mashek
Journal:  Mol Cell       Date:  2019-12-31       Impact factor: 17.970

9.  ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1α/PPAR-α signaling.

Authors:  Salmaan Ahmed Khan; Aishwarya Sathyanarayan; Mara T Mashek; Kuok Teong Ong; Edith E Wollaston-Hayden; Douglas G Mashek
Journal:  Diabetes       Date:  2015-02       Impact factor: 9.461

10.  Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.

Authors:  Sasmita Tripathy; Kelli A Lytle; Robert D Stevens; James R Bain; Christopher B Newgard; Andrew S Greenberg; Li-Shin Huang; Donald B Jump
Journal:  J Lipid Res       Date:  2014-05-09       Impact factor: 6.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.